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Background: To determine financial and quality of life impact of patients calling the ‘0845’ NHS Direct (NHS Direct)
telephone helpline from the perspective of NHS service providers.
Methods: Cost-minimisation of repeated cohort measures from a National Survey of NHS Direct’s telephone service
using telephone survey results. 1,001 people contacting NHS Direct’s 0845 telephone service in 2009 who agreed to
a 4-6 week follow-up. A cost comparison between NHS Direct recommendation and patient-stated first alternative
had NHS Direct not been available. Analysis also considers impact on quality of life of NHS Direct recommendations
using the Visual Analogue Scale of the EQ-5D.
Results: Significant referral pattern differences were observed between NHS Direct recommendation and
patient-stated first alternatives (p < 0.001). Per patient cost savings resulted from NHS Direct’s recommendation to
attend A&E (£36.54); GP Practice (£19.41); Walk-In Centre (£49.85); Pharmacist (£25.80); Dentist (£2.35) and do
nothing/treat at home (£19.77), while it was marginally more costly for 999 calls (£3.33). Overall an average per patient
saving of £19.55 was found (a 36% saving compared with patient-stated first alternatives). For 5 million NHS Direct
telephone calls per year, this represents an annual cost saving of £97,756,013. Significant quality of life differences were
observed at baseline and follow-up between those who believed their problem was ‘urgent’ (p = 0.001) and those
who said it was ‘non-urgent’ (p = 0.045). Whilst both groups improved, self-classified ‘urgent’ cases made greater health
gains than those who said they were ‘non-urgent’ (urgent by 21.5 points; non-urgent by 16.1 points).
Conclusions: The ‘0845’ service of NHS Direct produced substantial cost savings in terms of referrals to the other parts
of the NHS when compared with patients’ own stated first alternative. Health-related quality of life also improved for
users of this service demonstrating that these savings can be produced without perceived harm to patients.Background
NHS Direct was conceived and implemented in 1999 as a
telephone and Internet service through which patients and
the public could be ‘signposted’ to the most appropriate
health care resources to meet their immediate needs. By
2009 its service was being provided across 36 sites nation-
ally and was taking over 5 million telephone calls alone per
year [1]. NHS Direct has since undergone considerable re-
design to align its service delivery model to the require-
ments specified within the wider NHS reforms of the Out
of Hours urgent care pathway. It has been replaced by the
more comprehensive 111 service. Although the service is
restructuring, the economic lessons for similar services can* Correspondence: r.lambert@uea.ac.uk
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reproduction in any medium, provided the orbe learned about the efficiency of over-the-phone consulta-
tions and referrals from this comprehensive analysis of the
UK’s most far-reaching telephone health help-line service
to date.
In March 2009, a survey of 3,000 NHS Direct telephone
contacts was conducted by a market research company
(IFF Research Ltd) on behalf of NHS Direct. In April
2009, 1,001 of these callers who had agreed to be followed
up were contacted again.
The main aim of this evaluation was to determine the fi-
nancial impact, from the perspective of NHS service pro-
viders, of patients calling the ‘0845’ NHS Direct telephone
helpline. Previous studies of the impact of NHS Direct on
demand for other NHS services to date have been equivo-
cal, with examples of both increasing and decreasing cost
impacts [2-4]. Correspondingly there has been no clear
overall picture of savings or additional costs due to itsl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Lambert et al. BMC Health Services Research 2013, 13:300 Page 2 of 12
http://www.biomedcentral.com/1472-6963/13/300existence. It is also important to ascertain the impact on
the quality of care received arising from NHS Direct refer-
ral advice. To demonstrate this we adopted a cost-
minimisation approach that ensured any reduction in cost
was not at the expense of a poorer outcome. Despite need-
ing more substantiation of such benefits in further trials
we have been able to demonstrate that these users of NHS
Direct did maintain or improve their overall quality of life.
Methods
Two standardised telephone surveys of NHS Direct
telephone service users were conducted during 2009 by an
independent market research company acting on commis-
sion from NHS Direct. The first was a survey of 3,000
fifteen-minute telephone interviews conducted in March
2009, of callers to NHS Direct telephone services who had
consented to be contacted about their experience of NHS
Direct across all regions of England. This initial survey is
referred to as the ‘Main stage survey’. In this survey patients
explained what referrals had been suggested to them by
NHS Direct and 95.3% of patients stated that they followed
the NHS Direct recommendation. This was ‘service im-
provement’ evaluation and did not require full ethics com-
mittee approval. Nonetheless we followed a strict ethical
code in all aspects of the delivery and conduct of the study.
The range of reported referral options were standardised
into seven categories to enable direct comparison between
the groups (See Table 1). Patients were also asked about the
perceived urgency of their reason for initial contact with
NHS Direct and a range of quality of life measures. It
should be noted that urgency and quality of life issues could
only be undertaken for the actions recommended by NHS
Direct, as the first alternative was a hypothetical option
within the same population.
A second stage (‘economic impact survey’) telephone
survey was conducted during April 2009 (4-6 weeks after
the main stage). This was conducted with 1,001 callers from
the main stage survey who had consented to be included in
a second survey. This repeated the initial survey questions,
including the EQ-5D VAS scale and urgency measures.
Two methods were used to ensure that the survey data
used were robust and able to represent the general popula-
tion. The first method was that data in both surveys wereTable 1 Standard cost tariff




Dentist (not leading to admission) £57.00
A&E attendance £111.00
999 Ambulance Journey £344.00
Source: Curtis (2008).weighted to ensure that the proportion of people within
each referral option was representative of the national
population of NHS Direct telephone callers. It was felt,
however, that these weightings alone would not provide
sufficient reliability; therefore a sensitivity analysis was also
conducted to examine variance of results around key indi-
cators used. This two-stage approach provides assurances
that the reported findings are as robust as possible.
The acknowledged lack of a control group in this sur-
vey was addressed by asking callers ‘what service/s, if
any, they would have otherwise used had they not called
NHS Direct?’ Patients were subsequently followed up at
four to six weeks after their initial call to determine the
costs and consequences of their referral contact point. A
feature of the study was to administer the VAS quality of
life question as included in the EuroQol-5D (EQ-5D) by
telephone on initial call and again after treatment.
Standard NHS cost tariffs were applied to both the rec-
ommendations made by NHS Direct to its callers and to
the alternative action that the same callers stated they
would have taken if NHS Direct had not been available to
them. Although we asked for more than one ‘first alterna-
tive’ service (assuming a degree of risk), the additional alter-
natives were not consistently well answered and could not
be sufficiently relied on for further economic analysis.
Without a comparison group we had to accept the stated
first alternative as being the most likely alternative course
of action.
Whilst it would have been desirable to have included
NHS Direct’s operating costs, the costs of the ‘0845’ service
were under review at the time of the study. Therefore only
the gross saving could be estimated. However, it was the
scope of the referral savings to the NHS, not the wider
value of NHS Direct’s informational role, which was of
principal interest here.
The principal analysis was to examine the cost of NHS
Direct recommendations compared with patients’ stated
first alternative courses of action had NHS Direct not been
available. Although they were only within-subject controls
by adopting a cost-minimisation framework we were able
to show that health-related quality of life was maintained
by subjects actually taking up NHS Direct referrals.
Applying a standard tariff to each major referral option,
we produced a cost per case from which a cost difference
was derived. The cost tariff applied to each of the referral
options were taken from the available costs of Health and
Social Care 2007/08 [5] at the time of the study. These as-
sumptions are shown in Table 1.
The cost tariff applied was based on rational assumptions
of the most likely resource use. For example, the cost of a
contact to the GP/GP Practice was estimated using a 7-
minute contact time. In addition, the cost of a 999 ambu-
lance journey was based on a fully paramedic trained crew
being sent to each contact. This assumption also could not
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were not available. Therefore the assumptions used do not
include subsequent hospital costs or the proportion of pa-
tients who were treated and resolved by ambulance at-
tendance. Due to these assumptions, sensitivity analyses
were performed by increasing the cost of a GP/GP Prac-
tice contact from £19.17 to £31 (the cost of an 11-
minute consultation) to examine the impact of this as-
sumption on the overall costing analysis. Likewise, the cost
of a 999 Ambulance journey was varied between £344 and
£263 (the cost without a fully paramedic trained crew). We
conflated categories of referral used in the main stage sur-
vey and economic impact survey to integrate actual
and the stated hypothetical pathways (which were less
specifically described by actual users). No discounting of
these costs was applied to these estimates as they all oc-
curred within a few weeks after the intervention.
The first method used to ensure robustness was that
the number of respondents in this survey was adjusted
through a weighting procedure to take account of na-
tional patterns of NHS Direct use (assessed by previous
market surveys outside of this study). The population
sampled in this survey was also comparable to that in a
similar survey in 2008. We tested that the national
weightings applied did in fact lead to a close correlation
between predicted and observed proportions of patients
within each of the treatment options. We were satisfied that
this was indeed the case with less than a 1% variance from
the predicted proportion for all options (see Figure 1).
The costs were ‘grossed up’ to be indicative of the total
annual cost for 5 million calls per annum and thereforeCall 999 A&E GP/GP Practice
Observed Economic Impact 3.7% 8.5% 39.7%











Figure 1 Comparison of predicted and observed weighted proportionmore useful for policy purposes. It should be noted that
no such sample size weightings were applied to the quality
of life measures, since previous quality of life work had
not been undertaken and it was inappropriate to adjust
quality of life in this similar way.
Analysis
Analysis was based on descriptive statistics (frequencies
and cross tabulations) from the main dataset, carried out
using SPSS version 16. Some limited inferential statistics
were used to examine whether change observed was
statistically significant. This included Pearson Chi square to
examine between group resource use differences; paired t-
tests to examine quality of life change and Student’s
t-tests to compare Quality of Life change between ur-
gent and non-urgent cases. The outputs from SPSS were
transferred into Microsoft Excel 2003 for further analyses
during which the standard tariff costs were applied and
analysed and from which graphic representations of the
data were produced.
Results
The recommendations provided by NHS Direct were
significantly different to the options selected as the first
alternative if NHS Direct had not been available (Pear-
son Chi-Square p < 0.001) (see Table 2 - note that in this
table weighted figures have been rounded to whole num-
bers, and that application of the weighting results in a
total of 996 patients, rather than the original unweighted
sample of 1001 patients). Around 74% of first alternative
options were to A&E or GP Practice compared withWalk-In Centre Pharmacist Dentist
Do Nothing/Treat at 
Home
2.2% 7.0% 6.8% 32.2%
2% 7% 7% 32%
s of patients with in each treatment option.
Table 2 Cross tabulation of frequencies (Weighted) of the economic impact survey resource use for NHS Direct















Call 999 8 14 10 0 0 0 4 36 3.6%
A&E 3 48 24 3 0 0 7 85 8.5%
GP/GP Practice 8 92 205 23 8 0 61 397 39.9%
Walk-In Centre 1 9 6 4 0 0 1 21 2.1%
Pharmacist advice 0 15 35 5 8 0 6 69 6.9%
Dentist 0 18 8 0 0 26 15 67 6.7%
Do nothing/Treat at
home
6 105 147 20 9 3 31 321 32.2%
Total 26 301 435 55 25 29 125 996 100.0%
% 2.6% 30.2% 43.7% 5.5% 2.5% 2.9% 12.6% 100.0%
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trast, around 13% of first alternative options were to ‘do
nothing/treat at home’, compared with just over 32% from
NHS Direct recommendation.
To examine the cost differences between NHS Direct
recommendation and the patient’s stated first alternative, it
was important to recognise that the costs will be different
dependent on the perspective taken within the analysis. To
illustrate this difference, the figures for A&E attendance are
used.
Table 3 shows that 85.46 patients (the figures are not
whole numbers due to the applied weightings and are
provided to two decimal places for accuracy of grossing




Call 999 2.84 344
A&E 48.26 111
GP/GP Practice 23.74 19.17
Walk-In Centre 3.04 28
Pharmacist 0.47 4
Dentist £0.00 £57.00
Do nothing/Treat at home £7.10 £0.00
Total Patients
Recommended by NHS
Direct to attend A&E 85.46
Cost per A&E visit £111.00
NHSD recommendation
Total Cost
£9,485.73 Total cost of Patient
stated alternative
options to NHS Direct
recommendationA&E. The standard tariff for A&E attendance was £111
and therefore the cost of the NHS Direct recommenda-
tion is 85.46 × £111 = £9485.73. However, if the patient-
stated first alternative is examined in the same 85.46 pa-
tients, then it can be seen for example that 2.84 would
have called 999, 48.26 would have gone to A&E, 23.74
would have attended their GP Practice. By considering
all the first alternative options for this group of patients,
and costing these using the standard tariff, a total cost-
ing is established (for this example, the total cost is
£6,876.39). By dividing this total cost by the number of
patients, we find that the average cost of those patients’
first alternative options was £80.47. In this example








£1.89 Cost-per patient difference
£0.00 NHS Direct Recommendation to attend
A&E - Cost per patient
£111.00
£0.00 Patient stated 1st Alternatives - Cost
per patient
£80.47
Cost per patient difference £30.53
£6,876.39
Lambert et al. BMC Health Services Research 2013, 13:300 Page 5 of 12
http://www.biomedcentral.com/1472-6963/13/300is £30.53 less than attending A&E as recommended by
NHS Direct.
However, if the analysis is undertaken from the per-
spective of the patient-stated first alternative of attend-
ing A&E (and comparing the costs with those of the
NHS Direct recommendations made to this group of pa-
tients), then a different result is observed. Table 4 shows
that, from this perspective, the total cost of the 300.7 pa-
tients who stated they would have attended A&E is 300.7
× £111 = £33,377.45. This compares with a total of
£13,208.24 for the range of options recommended by NHS
Direct to those patients. The NHS Direct recommendation
is therefore £67.07 per patient less costly than the patient-
stated first alternative if NHS Direct had not been available.
By reviewing each of the other referral options simi-
larly, a comprehensive view of the costs from each per-
spective can be obtained. Figure 2 shows a summary of
these costs from the perspective of NHS Direct’s recom-
mendation compared with patients’ stated first alterna-
tive. From this perspective, NHS Direct is more costly
than the first alternative for 999 calls, A&E and dentist
appointments and less costly for the other options.
Alternatively, Figure 3 shows a summary of costs from
the perspective of the patient’s stated first alternative
compared with NHS Direct recommendation. From this
perspective, with the exception of Walk-in Centre, the
trends from Figure 2 are reversed.
Figure 4 shows the cost differences per patient from each
perspective for each referral option. For example, Figure 2
shows that the cost difference per patient for attending





Call 999 13.85 344
A&E 48.26 111
GP/GP Practice 92.29 19.17
Walk-In Centre 9.05 28
Pharmacist 14.58 4
Dentist 17.64 £57.00
Do nothing/Treat at home 105.04 £0.00
Total Patients who state they
would have attended A&E if
NHS had not been available
300.70
Cost per A&E visit £111.00
NHSD recommendation Total
Cost
£33,377.45 Total cost of Patient
stated alternative
options to NHS Direct
recommendationrecommendation, and Figure 3 shows this to be £67.07 less
costly when taking NHS Direct recommendation.
By representing the two perspectives together, it is
possible to consider the actual cost differences for each
referral option (See Figure 5). By considering the costs
from the perspective of the overall cost differential from
the previous analyses, an overall cost increase is ob-
served for patients following NHS Direct recommenda-
tion for calling 999 (£3.33 per patient) and up to £49.85
cost saving per patient with referral to a Walk-in Centre.
By taking this broader view of the data, the total costs/
savings of each referral option can be identified.
Figure 6 shows that, across all referral options,
NHS Direct costs £34.40 per patient, compared with
£53.95 per patient for the patient-stated first alterna-
tive. The difference between following NHS Direct
recommendation and a patient-stated first alternative
is therefore £19.55 per patient, representing a 36%
cost saving per patient. Assuming that these per pa-
tient cost savings from a survey of 1,001 current
users are representative across the 5 million telephone
contacts received per year by NHS Direct, the overall
cost saving is £97,756,013.
As stated earlier, since these savings are highly
dependent on unit cost assumptions, the second
method to ensure robustness was to conduct a sensi-
tivity analysis. The multi-way sensitivity analysis (see
Table 5) varied the costs of 999 calls between £344
(the cost of a fully paramedic trained crew) and £263
(the cost of a more basically trained crew). It also








£58.31 Cost-per patient difference
£1,005.35 NHS Direct Recommendation to
attend A&E - Cost per patient
£43.93
£0.00 Patient stated 1st Alternatives -
Cost per patient
£111.00

















NHS Direct £344.00 £111.00 £19.17 £28.00 £4.00 £57.00 £0.00















Figure 2 Weighted cost per patient of NHS Direct recomm endation compared with First Alternativ.
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GP time.
The sensitivity analysis also considered the effect of
the applied weightings and included analysis of
unweighted values and of both main stage and economic
impact datasets. This sensitivity analysis showed that the
weighted data produced less variance than the
unweighted datasets and that the costing assumptions
used in the main analysis also produced the lowest
variance compared with the additional varied assump-
tions. Therefore we consider the cost saving estimates






NHS Direct £128.49 £43.93 £24.98















Figure 3 Weighted cost per patient of First alternative compared withQuality of Life
Having estimated the costs, patient reported quality
of life outcomes were examined using the EQ-5D
VAS rating scale (0-100), guided by a telephone sur-
vey team. These were completed by 471/1001 (47%)
participants at baseline, and 469/1001 (47%) at
follow-up. Results showed that mean baseline score
was 57.37 points, and improved to a mean of 77.5 at
follow-up, an overall improvement of 20.1 points. A
paired t-test showed a highly significant difference
(p < 0.001; 95% CI = 18.42 to 23.95) between baseline











£16.37 £9.75 £51.20 £34.08











Cost per patient difference (NHS Direct vs First
Alternative)
£218.84 £30.53 -£25.22 -£38.22 -£31.55 £3.45 -£53.86
Cost per patient difference (First Alternative vs NHS
Direct)

















Figure 4 Cost per patient difference.
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spective of level of urgency, people who reported that
they considered their problems as urgent or non-
urgent gained between 16.1 (non-urgent) and 21.5
points (urgent) between baseline and follow-up. ThisCall 999 A&E
GP/GP
Practic









Figure 5 Net cost saving per patient.represented a significant ‘between group’ difference at
both baseline (p = 0.001; 95% CI = -15.63 to -2.96)
and follow-up (p = 0.046; 95% CI = -10.28 to -0.09),









1 £49.85 £25.80 £2.35 £19.77














Figure 6 Total weighted cost per patient.
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status between baseline and follow-up for each referral
option and by perceived urgency (see Figure 8), the
greatest improvement is achieved from urgent referrals to
Pharmacist (45.87 points), 999 calls (41.84 points), and
A&E (27.17 points). Figure 8 also shows the difference be-
tween urgent and non-urgent cases and in two of the seven
referral options urgent cases improve more than non-urgent
cases. In only two of the referral options (Dentist and
Do nothing/treat at home) is this trend reversed, with
non-urgent cases improving more than urgent ones.
It was not possible to calculate an incremental cost-
effectiveness ratio (ICER) in this study (as no control
group actually existed to compare incremental benefits).
However, as both costs reduced and outcomes improved
significantly the NHS Direct alternative can be considered
a ‘dominant’ option.
Discussion
Statement of principal findings
From an analysis of 1,001 users of the service, the cost of
NHS Direct recommendations across all referral options
was £34,430 compared with a total cost of the patient-stated
first alternative of £54,000. This is an overall cost saving of
£19,571 for this sample population. The cost per case of
the sample population following NHS Direct recommen-
dation was £34.40 compared with £53.95 for the patient-
stated first alternative, a cost saving of £19.55 (36%) per
patient. When this per patient cost saving is applied to the
5 million calls received by NHS Direct annually, the total
cost savings produced would be at least £97,756,013. The
sensitivity and variance analyses conducted demonstrated
this was a conservative, but robust estimate.However, quality of life is clearly an important consider-
ation when discussing effects of interventions in established
clinical pathways (and ultimate treatment patterns that
arise from these) and this must be weighed carefully
alongside any savings in resource use. The current analyses
have shown that overall the referral options recommended
by NHS Direct resulted in statistically significant positive
changes in quality of life between baseline and follow-up.
Clearly, what is still uncertain is whether these improve-
ments would have occurred anyway, either as a result of
following conventional referral pathways or through a
process of natural recovery, or both.
When looking at cases perceived by the patient to be
urgent or non-urgent (please note that 10 patients
responded with ‘Do not know’), there are more patients
contacting NHS Direct who consider their situation
as urgent (800 patients) than non-urgent (191 patients).
In terms of self-rated health status, recorded using a 0-
100 scale, statistically significant between group differences
were observed at baseline (Urgent = 55.28; Non-urgent =
65.83; p = 0.001), showing that urgent cases initially had
lower health status than non-urgent cases. At
follow-up, the differences between urgent and non-
urgent cases had reduced, but remained statistically
significant (Urgent = 76.78; Non-urgent = 81.97; p =
0.046), although the difference was smaller at follow-up.
Overall, this shows that urgent cases improved by a mean
of 21.5 points, compared with 16.1 points for non-urgent
cases.
When looking at the impact of the referral options
most often recommended by NHS Direct, patients
referred to a pharmacist, 999 call or A&E gained the
most benefit in terms of self-reported health status
Table 5 Sensitivity analysis
Variance from the average
999 = £344 +
GP = £19.17
999 = £263 +
GP = £19.17
999 = £344 +
GP = £31























£144,391,905.35 £140,861,394.77 £154,360,730.59 £150,830,220.01 £147,611,062.68 97.8% 95.4% 104.6% 102.2%
Mainstage
Weighted
£97,509,876.63 £101,684,902.29 £98, 708,
201.64








£97,756,012.97 £102,066,686.63 £100,031,550.35 £104,342,224.00 £101,049,118.49 96.7% 101.0% 99.0% 103.3%
Unweighted
Average
£127,492,980.65 £124,513,939.14 £136,288,756.91 £133,309,715.40 £130,401,348.02
Weighted
Average






















100.1% 100.2% 100.7% 100.7%















Figure 7 Self-related quality at baseline and follow-up by level of urgency.
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Urgent 41.84 27.17 18.92 16.61 45.87 12.27 23.92












Figure 8 Change in mean self rated health status between baseline and follow-up by urgency.
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urgent cases who are recommended to go to the
dentist or to ‘do nothing/treat at home’ improved
more than urgent cases.
The study has shown both a significant cost reduction
and an improvement in quality of life through the tele-
phone advice given by NHS Direct making this service a
cost-effective one. However, the findings still require fur-
ther investigation through a prospective study with a
true (rather than hypothetical) control group.
Strengths and weaknesses of the study
Most importantly, we did not have any formal control
group against which to view whether the level of change
results from the recommendations of NHS Direct. We
acknowledge that the present analyses rest on the hypo-
thetical comparison of what NHS Direct users said they
would have done if NHS Direct had not be available.
The cost assumptions used in these analyses have, of
necessity, omitted consideration of the outcomes
resulting from either accepting NHS Direct recommen-
dation, or the patient-stated first alternative. This may
under-estimate costs as it does not therefore include, for
example, call-outs by a GP or Ambulance crew who re-
solve problems without transfer to hospital, compared
with those that require further hospital-based treat-
ments. Likewise, the relative difference in costs of pa-
tients attending A&E are acknowledged to be different
depending on whether they are treated and sent home
or assessed and admitted. The sensitivity analyses
conducted focused on the elements where reasonable al-
ternative cost-assumptions were possible. However, it isalso felt that cost assumptions made have erred on the
side of caution and remained as robust as possible
within the limitations of available data.
The robustness of analyses has been assured through
a rigorous approach using both population weightings
and sensitivity analysis. During the sensitivity analysis,
both weighted and un-weighted findings were considered,
along with variation in relevant costing assumptions.
The final reported findings are based on the most ro-
bust combination.
Also from the initial survey a population of slightly less
than 50% completed the quality of life elements. This led to
difficulties in terms of the size of some sub-group analyses
which were too small to undertake adequate analyses.
Consideration of the quality of life and urgency issues
could only be undertaken from the perspective of NHS
Direct recommendation, as any attempt to consider
these issues from the perspective of the patient-stated
first alternative would have remained hypothetical and
would have been from the same sample population.
Therefore it was only possible to review this data to
examine whether improvement occurred between the
main stage and economic impact surveys.
The lack of any case-mix adjustment, apart from
the reported urgent/non-urgent dichotomy, is a po-
tential weakness of this study. However, this was
controlled by the within-subject design. Also, the
sample size did not allow case-mix cost variation to
be identified whilst the survey method (of telephone
delivery) made it difficult to determine an actual
diagnosis. Hence the results should be treated cau-
tiously if intending to apply them to any specific
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fully consider case-mix issue.
The analysis did not include any indication of appro-
priateness. This would have required a much bigger
study. For example, If NHS Direct recommended going
to A&E, and the first alternative was to do nothing, we
did not know how serious the problem really was and
what implications (such as a worsening condition) could
have arisen from the ‘do nothing’ option, or from attending
A&E (such as being admitted, etc.).
Strengths and weaknesses in relation to other studies
(discussing important differences in results)
Early in its development, there was recognition that NHS
Direct required rigorous evaluation [6]. Such evaluation
was recommended to address the five key issues below:
 Ensure NHS Direct is safe and effective
 To develop National Standards
 To become an integral part of the NHS
 To ensure equity of access for all
 To provide a range of systems for access [6]
The current study had a key bearing on the third of these
and has concluded in a preliminary way that integration
into the NHS has taken place at least as far as being able to
refine the initial point of NHS contact at less cost and with-
out damage to immediate health outcomes.
One of the first formal evaluations of NHS Direct was
an observational study, identifying that the service had
received about 68,500 calls in its first year [4]. This initial
study concluded that NHS Direct had restrained increas-
ing demand on General Practitioner out-of-hours services.
Another study a year later identified that levels of urgency
was often not recorded, and that a quarter of calls related
to 0-5 year olds [7]. At about the same time, unintended
consequences were being noted, in that while advice calls
to A&E were observed to have significantly reduced, calls
to the main hospital increased [8].
One of the first cluster randomised trials of NHS Direct
[9] identified that NHS Direct triage was more costly
than practice based triage. However, no formal eco-
nomic evaluations of NHS Direct have been reported
in peer-reviewed journals.
Many of the studies of NHS Direct were conducted in
its earlier period of development and this current study
provides evidence of its use and cost-effectiveness in a
mature phase after ten years of existence. The current
study shows that around 40% of patients were
recommended by NHS Direct to go to their GP Practice
and around the same proportion would have elected to go
to the GP Practice had NHS Direct not been available.
However, there were almost three times as many people
recommended by NHS Direct to ‘do nothing/treat athome’, than would have taken this option without NHS
Direct. This indicates that the demand management value
of NHS Direct on general practice at least remains high
even after ten years.
The fact that we have undertaken evaluation by level
of urgency shows that the critique by Payne et al (2005)
[7] has been addressed. Future studies will need to
stratify patient user groups in similar and perhaps
more refined ways if the economic impact is to be more
carefully interpreted. Another factor is that Payne et al
(2005) [7] suggested that 25% of calls to NHS Direct were
for children 0-5 years. Our current analysis does not
provide a comparable age grouping, but shows that
nearly half (44.8%) of calls were on behalf of children
under 16 years of age.
Despite earlier indications [9] that NHS Direct was
more costly than practice based triage, the current ana-
lysis shows that before its own costs are excluded NHS
Direct recommendation is £19.55 less costly to the NHS
than the patient-stated first alternatives.Meaning of the study; possible explanations and
implications for clinicians and policy makers
The current study used National Survey data to examine
the financial and quality of life implications of NHS Direct
telephone recommendation when compared with patients’
own statements about what alternative actions they
would have taken had NHS Direct not been available.
The outcomes from this analysis show NHS Direct is
making substantial patient-level cost savings compared
with their likely service use if NHS Direct was not in
place. It also shows an observed improvement in qual-
ity of life between the main stage and follow-up sur-
veys. However it could be argued that this quality of
life profile change would be observed anyway given the
natural recovery process from some acute health epi-
sode. Therefore, quality of life changes require further
examination, although the initial conclusion is that
NHS Direct overall improves both quality of life and
cost over stated alternatives.Unanswered questions and future research
Major questions unanswered by the current study are
related to whether the cost savings and quality of life
improvements can be observed if there was a genuine,
rather than a hypothetical, control group? This requires a
larger, well designed and well funded research study also
consisting of subjects who may not have decided to use
NHS Direct.
Further consideration should be given to undertaking
more detailed research with the following features:
A prospective study design for more accurate cost
estimation.
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group of patients who did not use NHS Direct (but could
have done).
A well designed cohort study, comparing the cost-
effectiveness of NHS Direct recommendation against an
age-, gender and condition-matched control by each
major referral recommendations by NHS Direct.
Conclusions
Studies of NHS Direct’s impact on demand for other NHS
services to date have been equivocal, with examples of both
increasing and decreasing demand effects as a result of
early intervention in the patient referral pathways [2-4].
Therefore there has been a lack of clarity as to the eco-
nomic implications of the service and no clear overall pic-
ture of savings or additional costs due to its existence. In
recent years there appears to have been an increasing trend
in the use of NHS Direct services, including the ‘0845’
number, which now stands at 5 million calls per annum.
Although these are early economic results, they show
some robust impacts on pattern of NHS contact compared
to what patients said they would otherwise have done with-
out NHS Direct. This study of 1,001 individuals showed a
significant reduction in potential use of A&E and GP visits
by about 25% and a 10% increase in patients who decided
to do nothing/treat at home following NHS Direct advice.
These changes caused an overall reduction in the expend-
iture on initial NHS contacts of the equivalent of about £20
per call, or a 36% saving in referral cost overall. Some
savings were higher, such as those that would have been
incurred at Walk-in Centres (£50 per patient) or those visit-
ing a Pharmacist (£26 per patient). Obviously, if the average
magnitude of saving can be extrapolated to every NHS
Direct caller then the potential for savings is large and will
grow with further usage.
We found evidence that the health status of users of
NHS Direct (as measured by the VAS scale of the EQ-5D),
showed significant improvement. This should offer much
greater reassurance to clinicians and policy makers that
patients can be dealt with initially equally as well but at
significantly less cost by NHS Direct compared to conven-
tional pathways.
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